Track ESPR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
ESPR - Esperion Therapeutics Inc (ESPR) has a earnings per share of -$0.10, up 52.4% over the past year.
Latest EPS (Actual)
-$0.10
Beat Rate
50.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.04 | -$0.10 | Miss | -150.00% |
| Mar 2026 | $0.28 | $0.22 | Miss | -21.43% |
| Nov 2025 | -$0.08 | -$0.16 | Miss | -100.00% |
| Aug 2025 | -$0.16 | -$0.02 | Beat | +87.50% |
| May 2025 | -$0.15 | -$0.21 | Miss | -40.00% |
| Feb 2025 | -$0.16 | -$0.10 | Beat | +35.68% |
| Nov 2024 | -$0.17 | -$0.15 | Beat | +11.76% |
| Aug 2024 | -$0.17 | -$0.05 | Beat | +70.59% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.